Literature DB >> 14990988

Identification of Tcf-4 as a transcriptional target of p53 signalling.

Karen Rother1, Cindy Johne, Katja Spiesbach, Ulrike Haugwitz, Katrin Tschöp, Mark Wasner, Ludger Klein-Hitpass, Tarik Möröy, Joachim Mössner, Kurt Engeland.   

Abstract

T-cell factor (Tcf)-4 is a main transcription factor to pass on Wnt/beta-catenin signalling. The tumour suppressor protein p53 contributes as a transcription factor to cell-cycle arrest and apoptosis induction. Mutations of components in p53 and Wnt/beta-catenin signalling networks play a part in tumour formation. Here, we identify the Tcf-4 gene as a downstream effector of p53. Induction of wild-type p53 in a tet-off regulated human colon cell system leads to the reduction of Tcf-4 mRNA and protein levels. Also, mRNA of the Tcf-4 target gene uPAR is downregulated after p53 induction. Expression of a luciferase reporter controlled by the Tcf-4 promoter is repressed by wild-type p53, but not by a p53 mutant deficient in DNA binding. Such a regulation is seen in cell lines of different origin. These findings directly link Wnt/beta-catenin signalling and p53 tumour suppressor function and may provide a mechanism by which loss of p53 function contributes to progression in the adenoma/carcinoma sequence in colon tumours. Furthermore, since Tcf-4 is expressed in many tissues and downregulation of Tcf-4 by p53 is seen in several different cell types, this regulation likely plays a role in proliferation control of all tissues that can express p53 and Tcf-4. Copyright 2004 Nature Publishing Group

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990988     DOI: 10.1038/sj.onc.1207464

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  Activation of p53 by Dishevelled independent of Wnt or planar polarity pathways.

Authors:  Vivianne W Ding; Li-Ping Lin; Andrew L Chiang; Frank McCormick
Journal:  J Mol Med (Berl)       Date:  2007-06-26       Impact factor: 4.599

2.  p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro.

Authors:  Hong-Chuan Zhao; Qi Zhang; Yang Yang; Min-Qiang Lu; Hua Li; Chi Xu; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

3.  E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8.

Authors:  Erick J Morris; Jun-Yuan Ji; Fajun Yang; Luisa Di Stefano; Anabel Herr; Nam-Sung Moon; Eun-Jeong Kwon; Kevin M Haigis; Anders M Näär; Nicholas J Dyson
Journal:  Nature       Date:  2008-09-14       Impact factor: 49.962

4.  Capsaicin represses transcriptional activity of β-catenin in human colorectal cancer cells.

Authors:  Seong-Ho Lee; Raphael L Richardson; Roderick H Dashwood; Seung Joon Baek
Journal:  J Nutr Biochem       Date:  2011-07-20       Impact factor: 6.048

Review 5.  Regulation of cell signalling by uPAR.

Authors:  Harvey W Smith; Chris J Marshall
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

6.  Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells.

Authors:  Lian-He Yang; Hong-Tao Xu; Yang Han; Qing-Chang Li; Yang Liu; Yue Zhao; Zhi-Qiang Yang; Qian-Ze Dong; Yuan Miao; Shun-Dong Dai; En-Hua Wang
Journal:  Mol Cancer       Date:  2010-02-02       Impact factor: 27.401

Review 7.  The role of the p53 tumor suppressor in metabolism and diabetes.

Authors:  Che-Pei Kung; Maureen E Murphy
Journal:  J Endocrinol       Date:  2016-09-09       Impact factor: 4.286

8.  Transient activation of Wnt/{beta}-catenin signaling induces abnormal growth plate closure and articular cartilage thickening in postnatal mice.

Authors:  Takahito Yuasa; Naoki Kondo; Rika Yasuhara; Kengo Shimono; Susan Mackem; Maurizio Pacifici; Masahiro Iwamoto; Motomi Enomoto-Iwamoto
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

9.  Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China.

Authors:  Guangyu Ma; Hideaki Shimada; Kenzo Hiroshima; Yuji Tada; Nobuo Suzuki; Masatoshi Tagawa
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

10.  Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines.

Authors:  Marcy E Beildeck; Md Islam; Salimuddin Shah; Joellen Welsh; Stephen W Byers
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.